In volume 38, pp 5-6, May 2006 of Bone Marrow Transplantation, Frassoni wrote a short article on in vitro fertilization and embryo research in which he strongly criticizes the law 40/2004 approved by the Italian parliament. 1 He is very much concerned about the ban on embryonic stem cell research and the restrictions laid on in vitro fertilization. The Italian law rules that no more than three eggs at a time can be fertilized, and that all of the resulting embryos must be implanted simultaneously.
In our opinion, the most important issue is to define the biological and ontological status of the embryo. In this context, we would like to stress a few points based on biological data. From the moment the spermatozoon enters the egg, two fundamental characteristics emerge: (a) the new system is not simply the sum of the two subsystems but a new unit that cannot be compared to either the oocyte or the spermatozoon and (b) this event gives rise to development with absolutely original features: coordination, continuity and gradualness. 2 The differentiation process begins almost at the same time. 3 Pearson wrote that 'where your head and feet would sprout, and which side would form your back and which your belly, were being defined in the minutes and hours after sperm and egg unite'. 4 The conclusion inferred from the biological data available today is that from the moment of fertilization the embryo is an individual human being who is beginning his life cycle, 5 and is thus worthy of protection and respect. Thus, when you destroy an embryo you are destroying a human life.
Given these preliminary remarks, we would like to voice our disagreement with Frassoni who affirms that law 40/ 2004 contrasts with the law of abortion. We certainly agree that the abortion law permits prenatal diagnosis, but this only leads to abortion when the mother's health (within the first 3 months of gestation) or her life (within the second 3 months of gestation) are in serious danger. In fact, this law was introduced to safeguard the mother when there is a 'conflict of interest' between the health and survival of the two human beings. Conversely, preimplantation diagnosis makes it possible to destroy embryos that have a genetic defect or that are in any way unhealthy which, had it been permitted, would strongly contradict the abortion law.
Frassoni argues that before law no. 40/2004, in vitro fertilization in Italy involved the production of several embryos; embryos not implanted could be cryopreserved and used for scientific purposes. Now that this law has become effective, no extra embryos can be stored for research anymore.
So described, the Italian scenario could lead to the impression that law no. 40 represents a threat to progress in that it forbids the use of an incredible amount of potentially useful biological material. According to a survey by the embryologist Jacob Mayer, only about 275 of the roughly 400 000 frozen embryos currently stored in the US are likely to be of any use to stem cell research, considering that few couples have given their consent, that many of the embryos will not have survived freezing and finally that only 25% of those surviving are expected to develop to the blastocyst stage. 6 Instead, we believe that oocyte cryopreservation offers a viable solution to the ethical problems of embryo storage, particularly considering the good survival and fertilization rate of this safe and efficient technique. 7 Furthermore, Frassoni describes a dramatic future scenario: in some parts of the world it will be possible to treat several conditions with embryonic cells, whereas Italian patients will hardly have access to these opportunities. European Union member states have different legal regulations; Belgium, UK and Sweden allow research using therapeutic cloning and embryonic stem cells; Denmark, Finland, France, Greece, Spain and the Netherlands have regulations allowing the derivation of new human embryonic stem cells from supernumerary in vitro fertilized embryos; in Germany, scientists cannot create new human embryonic stem cells, but can import them if they were derived before 1 January 2002; Austria, Ireland and Poland have legislation prohibiting human embryonic stem cell research. In the recently approved 7th Framework Research Programme, the European Union explicitly excludes from Community funding research activities intended to create human embryos solely for the purpose of research or for the purpose of stem cell procurement, including by means of somatic cell nuclear transfer. By far, the largest part of Community funds for stem cell research is devoted to the use of adult stem cells. A European registry of human embryonic stem cells in Europe will be supported in order to maximize their use by scientists and to avoid unnecessary derivations of new stem cells (for further details see website http://www.eurostemcell.org).
At this point we find it necessary to recall that although the number of human embryonic stem cells has considerably increased over the past years, few of them have been well characterized, and clinical results on humans are not yet available; 'commercial companies are springing up around the world with all the fervor of a new biological era, but with selective memory loss for the fact that unrealistically high expectations burst that bubble'. 8 Conversely, adult stem cells have been used several times in more than 80 pathologies; moreover, a process named 'developmental plasticity' has been postulated, introducing a new therapeutic concept in tissue regeneration.
Whatever the case, law no. 40 does not forbid the use of embryonic stem cells but it forbids the procurement and destruction of human embryos. We hope in the foreseeable future that new techniques will be developed to obtain embryonic-like stem cells without having to destroy the embryos. Indeed, law no. 40, not rejected by the majority of Italian people, could be changed with regard to some points such as the possibility of distinguishing genetic defects in gametes before fertilization. Nonetheless, it expresses a clear viewpoint on the biologically and ethically complex issue of in vitro fertilization and embryonic stem cell research. Concerning the abortion law, Drs Caocci and Pisu simply forget that within the first 3 months of pregnancy, law no. 194 allows the mother to terminate the pregnancy irrespective of the health status of the mother and the baby. For the remaining part of the letter dealing with stem cell research, Drs Caocci and Pisu use the arguments that nearly all supporters of law no. 40 have been using in recent years: (1) there is not yet evidence that embryonic stem (ES) cells could be exploited for therapeutic purposes (I agree, but this is not sufficient to ignore ES research); (2) adult stem cells have been used several times in more than 80 pathologies (but most of them concern hematopoietic cell transplantation). I know that therapy based on embryonic stem cells is not just around the corner. The future involves research on both adult and ES cells. The problem is that Italian science will suffer from such apartheid. Knowledge has a value per se.
G
I have also clearly stated that the research should be under the auspices of the public institution. Thus, I do not understand why the issue of commercial companies was raised. However, I can further comment by saying that in times of prohibition, there is indeed the risk that commercial companies will take over the market whereas the public institutions are inhibited from carrying out research and development. The United States America has been in a paradoxical situation for some time: no public funding for ES research but free research and development with private money. However, in the USA things are changing, as several states, such as California, have approved huge investments on ES research.
As I stated in my commentary, with law no. 40, Italy takes the opposite stance with respect to the majority of the western countries. Some people seem proud of it. Historically, in the last century, it was considered that this position was never associated with a very good outcome. Secondly, if 'the relative chance of existing' refers to the existence of a human being, we reported that the life of a human being already exists at the moment of fertilization, thus to introduce a choice between existing or not is a paradox. If 'the relative chance of existing' means the opportunity to continue to live, we think that to confuse the right of living with the expectation of life is a perilously tight corner from which it is hard to get out.
